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Abstract
In the past decade, researchers have been able to obtain pluripotent stem cells
directly from an organism’s differentiated cells through a process called cell reprogram-
ming. This opens the way to potentially groundbreaking applications in regenerative
and personalized medicine, in which ill patients could use self-derived induced pluripo-
tent stem (iPS) cells where needed. While the process of reprogramming has been
shown to be possible, its efficiency remains so low after almost ten years since its con-
ception as to render its applicability limited to laboratory research. In this paper, we
study a mathematical model of the core transcriptional circuitry among a set of key
transcription factors, which is thought to determine the switch among pluripotent and
blue early differentiated cell types. By employing standard tools from dynamical sys-
tems theory, we analyze the effects on the system’s dynamics of overexpressing the core
factors, which is what is performed during the reprogramming process. We demonstrate
that the structure of the system is such that it can render the switch from an initial
stable steady state (differentiated cell type) to the desired stable steady state (pluripo-
tent cell type) highly unlikely. This finding provides insights into a possible reason for
the low efficiency of current reprogramming approaches. We also suggest a strategy for
improving the reprogramming process that employs simultaneous overexpression of one
transcription factor along with enhanced degradation of another.
1 INTRODUCTION
Stem cells are unspecialized precursors with the potential to differentiate into more special-
ized, differentiated cell types. In particular, embryonic stem cells (ESCs) are at the top of
the differentiation hierarchy and can give rise to any cell in an organism [2]. This makes
them popular candidates for use in regenerative and therapeutic medicine, where they can
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replace a patient’s injured or diseased adult cells [3–9]. However, ESC therapies face a cou-
ple of major limitations. ESCs derived from early fetal cell masses confront various ethical
controversies [10], and transplanting another organism’s stem cells into a patient runs the
risk of failed engraftment due to the patient’s immunogenic barrier [11].
The biological and ethical factors limiting the efficacy of ESCs make iPS cells a much
more preferred alternative, since they face neither of these issues by their very nature. First
discovered in a seminal experiment by Yamanaka et. al in 2006, iPS cells were produced
by overexpressing only four pluripotency-related transcription factors in differentiated cells
[12]. Since then, this strategy has been used to create a variety of iPS cells from various
differentiated cell types [13]. However, there is still a large bottleneck in iPS cell research
due to the low efficiency of reprogramming in these experiments, generally around 1% or
much less [14–16].
In this paper, we investigate structural aspects of these overexpression-based repro-
gramming strategies to explain potential reasons for this failure. Specifically, we study the
dynamics of three transcription factors–Oct4, Sox2, and Nanog (OSN)–which have emerged
as the master regulatory factors involved in pluripotency [17–23]. Specific levels of OSN
characterize three cell types, each represented by a stable steady state (SSS) of the dynamic
model of the OSN network. These include the iPS cells (which correspond to the pluripotent
ESCs) and their more differentiated counterparts, the trophectoderm (TR) and primitive
endoderm (PE) cells (which are multipotent).
Our dynamical systems approach is related to the well-established Waddington epige-
netic landscape metaphor [24]. In the Waddington framework, phenotypical cell types are
represented as basins of attraction in a landscape of equilibria. In this model, biological
cell differentiation is understood as a transition between attractors’ basins due to stimuli
applied to the underlying genetic network [25]. In our specific case, the ESC, TR, and PE
states are basins of attraction, and the reprogramming process aims at transforming a state
in the TR (or PE) basin of attraction to a state in the ESC basin of attraction.
This paper is organized as follows. In Section II, we begin with a 3D ordinary differential
equation (ODE) model for the dynamics of OSN, which we reduce to a 2D ODE model
between Oct4 and Nanog. We then use nullcline analysis to characterize the ESC, TR, and
PE cell types as stable steady states in the 2D model. In Section III, we investigate the
dynamics of overexpression-based reprogramming. We discover that current overexpression
strategies rarely succeed in reprogramming differentiated cells (in this case, TR or PE cells)
into pluripotent cells (ESCs, or iPS cells), due to the nullclines’ structure. In addition, we
present a strategy based on the 2D nullcline portrait to improve reprogramming outcomes
using simultaneous overexpression of one factor and enhanced degradation of another.
2 Model
2.1 The Oct4-Sox2-Nanog Fully Connected Triad
Fig. 1 summarizes the early embryological steps a zygote undergoes after fertilization to
divide and differentiate into cells with decreasing plasticity. These are the differentiation
steps which give rise to the three cell types of interest: ESCs, TRs, and PEs. The working
hypothesis of the identity of the molecular machinery dictating which cells go down each
path in either differentiation step is the Oct4-Sox2-Nanog network [17–23]. We approximate
Figure 1: (A) In the first steps after fertilization, three rounds of cell division form an 8-cell mass
known as the morula. (B) The first differentiation event occurs when an epithelial layer known as
the trophectoderm (TR) forms around the perimeter of the mass, leaving the rest of the cells in
an inner cell mass (ICM), (from which ESCs are derived [28, 29]), pushed against the blastocoel
cavity. (C) The second differentiation event occurs when ICM cells adjacent to the blastocoel form
an epithelium known as the primitive endoderm (PE), leaving the rest of the cells to the epiblast
lineage. This figure was created using [30].
the topology of this network as a fully connected triad (FCT) among Oct4, Sox2, and Nanog,
as shown in Fig. 2. FCTs are a class of 3-node network motifs in which all nodes directly
interact with one another. In particular, when these interactions are all activations, these
special FCTs have been shown to exhibit the desired multi-stability properties we seek [26].
The FCT we model here contains an additional repression mechanism, which has been more
recently suggested [27].
2.2 The Nonlinear 3D OSN Model
Referring to the topology of Fig. 2, the following ordinary differential equation model based
on cooperative Hill functions [31] is employed to describe the dynamics of the FCT. Let
N,O and S represent the concentrations of Nanog, Oct4, and Sox2, respectively. The model
is given by
Σ3D
dN
dt
=
a1OS + b1N
2 + c1OSN
2 + η1
1 +OS +N2 + γOSN2 + dOm
− k1N = f1(N,O, S)− k1N, (1)
dO
dt
=
a2OS + b2N
2 + c2OSN
2 + η2
1 +OS +N2 + γOSN2
− k2O = f2(N,O, S)− k2O, (2)
dS
dt
=
a2OS + b2N
2 + c2OSN
2 + η2
1 +OS +N2 + γOSN2
− k2S = f2(N,O, S)− k2S. (3)
In the ODEs above, the linear terms are due to dilution and degradation, and all pa-
rameters are positive. The nonlinear Hill function terms, denoted by fi (i=1,2), model the
species’ interaction with one another. Specifically, the Hill functions incorporate activation
Figure 2: The net-
work of Oct4, Sox2,
and Nanog modeled
as a fully connected
triad (FCT).
by the heterodimer OS, the homodimer N2, and the molecule OSN2. Additional features
and assumptions of model Σ3D are described below.
2.2.1 Nanog Dimerization
In contrast to the models of [32, 33], which consider Nanog as a monomer, it is treated as
a homodimer (N2) in Σ3D. This is based on strong evidence suggesting Nanog only binds
to other pluripotency factors when dimerized [34,35].
2.2.2 Independent Nanog Promoter Activity
The models of [32, 33] only consider activation by Nanog when this species is bound to
the Oct4-Sox2 heterodimer. While it has been shown that binding Oct4-Sox2 significantly
strengthens activation by Nanog [36], the species can still act as an activator – albeit a
much weaker one – when not bound to the heterodimer. In [36], activation by Nanog when
one or both of Oct4 and Sox2 were mutated was reduced to between 6-17% of wild type
activity. To capture this, independent N2 activator terms are included in the Hill functions
of Σ3D. We note the rough quantitative constraint on the relative strength of this term
to the OSN2 term when determining appropriate values for the bi and ci parameters in
sections below.
2.2.3 Repression of Nanog by Oct4
In [27], it was reported that low levels of Oct4 were correlated with high Nanog and higher
levels of Oct4 were correlated with low Nanog. Although no regulatory link was demon-
strated, we model this empirical observation with a higher order repressive term by Oct4
on Nanog, (dOm,m > 2), as seen in (1). Based on evidence suggesting Oct4 forms a
heterodimer with Sox2 [37], we require that the order of repression is an even number.
2.2.4 Equal Dynamics for Oct4 and Sox2
Given that Oct4 and Sox2 are known to work together [38] and have been considered as
the same species in previous models [27], here we assume that their dynamics are the same.
This simplifies the analysis without affecting the main conclusions.
2.2.5 Denominator Constant Normalization
The standard form of a Hill function for an activator xa is a1(xa/ka)
n/(1 + b1(xa/ka)
n),
and for a repressor xr it is 1/(1 + b1(xr/kr)
n) [31]. As seen in (1)-(3), the parameters are
normalized as follows. Given a Hill function of the form
f(x, y) =
α1(
x
κ1
)n1 + α2(
y
κ2
)n2 + α3(
xy
κ3
)m
1 + β1(
x
κ1
)n1 + β2(
y
κ2
)n2 + β3(
xy
κ3
)m
, (4)
the substitutions X := β
(1/n1)
1
x
κ1
, Y := β
(1/n2)
2
y
κ2
allow (4) to be rewritten as
f(X,Y ) =
α′1Xn1 + α′2Y n2 + α′3(XY )m
1 +Xn1 + Y n2 + γ(XY )m
, (5)
where α′1 := α1/β1, α′2 := α2/β2, α′3 := α3
[
κ1κ2
κ3
1
β
1/n1
1 β
1/n2
2
]m
, γ := β3
[
κ1κ2
κ3
1
β
1/n1
1 β
1/n2
2
]m
.
2.3 Model Reduction into a 2D System
To study the location and stability of the steady states of Σ3D, we study a reduced order
system given by
Σ2D
dN
dt
=
a1O
2 + b1N
2 + c1O
2N2 + η1
1 +O2 +N2 + γO2N2 + dOm
− k1N = g1(N,O)− k1N, (6)
dO
dt
=
a2O
2 + b2N
2 + c2O
2N2 + η2
1 +O2 +N2 + γO2N2
− k2O = g2(N,O)− k2O, (7)
which is obtained by substituting S = O in (1) and (2). We justify this reduction with
the trivial fact that S = O is an invariant and globally attractive subspace of Σ3D. By
virtue of this fact, we can focus on studying the number and stability of the steady states
of Σ2D.
2.4 Characterizing ESC, Tr, PE States by Oct4 and Nanog Levels
Using experimental studies of the differentiation steps that give rise to the ESC, TR, and
PE states, Table 1 summarizes the results of a literature search concluding with the char-
acterizations of the three cell types shown in Fig. 3. While the experiments show that
Nanog levels in ESC are much higher than those in TR and PE, we found no experimental
evidence comparing Nanog levels in TR and PE. We assume that Nanog in PE is slightly
higher than Nanog in TR. There is no loss of generality in doing so because the strength of
the parameter d in (6) can be chosen to further decrease Nanog levels for high Oct4. With
this characterization and the mathematical framework established above, we now form a
correspondence between the SSS of Σ2D and the physiological cell types corresponding to
certain levels of Oct4 and Nanog.
Oct4
Levels
TR <ESC ESC <PE
[39–42] [41–43]
Nanog
Levels
TR, PE <ESC
[19, 23,44]
Table 1: Results of literature search characterizing Oct4 & Nanog levels in TR, ESC, PE cell states
Figure 3: State charac-
terizations of ESC, TR,
and PE based on relative
Oct4 and Nanog con-
centrations determined
from Table 1.
2.5 2D Nullcline Analysis
We perform nullcline analysis to determine the SSS corresponding to the qualitative levels
of Oct4 and Nanog in each cell type seen in Fig. 3. Equilibria (N∗, O∗) are determined by
intersections of the nullclines
N∗ =
√
k2O∗ − a2O∗2 + k2O∗3 − η2
b2 − k2O∗ + c2O∗2 − k2O∗3 , (8)
O∗+/− =
√
−1
d +
a1
dk1N∗ +
c1N∗
k1d
− N∗2d ± Z
2
, (9)
where we have defined
Z :=
1
k1dN∗
[(−a1 + k1N∗ − c1N∗2 + k1N∗3)2
− 4dk1N∗(k1N∗ − b1N∗2 + k1N∗3 − η1)]1/2, (10)
and have set the order of Oct4 repression on Nanog to m = 4 for the sake of analysis.
The main parametric constraint used when performing this analysis was that the strength,
bi, of activator N
2 should be less than the strength, ci, of OSN
2–on the order of about 0.10.
This is in accordance with the experimental report [36] showing Nanog promoter activity
when Oct4 and Sox2 were mutated was measured to be much less than wild type activity
(6-17%). In Fig. 4, nullclines are shown for a representative parameter set which satisfies
these constraints (b1/c1 ≈ 0.27, b2/c2 ≈ 0.09). There are five steady states, whose stability
is studied through geometric reasoning as follows.
We define H1(N,O) := g1(N,O)−k1N,H2(N,O) := g2(N,O)−k2O. We first study the
stability of a point (N,O) on the nullcline H2(N,O) = 0 (Fig. 4B) in the O direction. For a
fixed N , the corresponding point on the nullcine is stable in the O direction if ∂H2/∂O < 0.
Using the implicit function theorem, we have
dO
dN
∣∣∣∣
H2=0
= −∂H2
∂N
·
(∂H2
∂O
)−1
. (11)
Graphically, the left hand side in (11) represents the local slope of the nullcline in Fig. 4B.
In our system, ∂H2/∂N > 0 for all positive (N,O). Therefore, ∂H2/∂O < 0 if and only if
dO/dN > 0. As a result, a point (N,O) on the nullcline H2(N,O) = 0 is stable in the O
direction if and only if dO/dN is positive at (N,O).
Similarly, when studying the stability of a point (N,O) on H1(N,O) = 0 in the N
direction, we consider the nullcline dN/dt = H1(N,O) = 0 in Fig. 4C. For a fixed O, the
steady state is stable in the N direction if ∂H1/∂N < 0. Applying the implicit function
theorem, we obtain the condition that the steady state is stable if and only if( dO
dN
∣∣∣∣
H1=0
)
· ∂H1
∂O
> 0, (12)
where the first term in (12) is the local slope of the nullcline in Fig. 4C. In contrast to
the previous case, however, ∂H1/∂O is not sign definite when evaluated on the nullcline
H1(N,O) = 0. To understand which segment of the nullcline in Fig. 4C has positive
(negative) ∂H1/∂O, we note that for a fixed N = N
∗, O is solved by a quadratic function
of O2,
Hˆ1(N
∗, O) := H1(N∗, O)T (N∗, O) = −a(N∗)O4 + b(N∗)O2 + c(N∗) = 0, (13)
where a = −k1dN∗, b = a1 − k1N∗ + c1N∗2 − k1N∗3, c = −k1N∗ − k1N∗3 + b1N∗2 + η1 and
T (N∗, O) := 1+O2+N∗2+γO2N∗2 > 0 is the denominator term in g1(N∗, O∗). When (13)
has two solutions O∗− (red branch in Fig. 4C) and O∗+ (blue branch in Fig. 4C), we have
∂Hˆ1
∂O (N
∗, O∗−) > 0 and
∂Hˆ1
∂O (N
∗, O∗+) < 0. Moreover, since H1(N∗, O∗−) = 0 at (N∗, O∗−),
∂Hˆ1
∂O
(N∗, O∗−) = H1(N
∗, O∗−) ·
∂T
∂O
(N∗, O∗−)
+
∂H1
∂O
(N∗, O∗−) · T (N∗, O∗−)
=
∂H1
∂O
(N∗, O∗−) · T (N∗, O∗−) > 0, (14)
which implies that ∂H1/∂O > 0 at (N
∗, O∗−). Similarly, we can show that ∂H1/∂O < 0 at
(N∗, O∗+). Therefore, the red branch (corresponding to O∗−) is stable (unstable) in the N
direction when the local slope of the nullcline in Fig. 4C is positive (negative). Conversely,
the blue branch (corresponding to O∗+) is stable in the N direction when the nullcline has
negative local slope, and unstable otherwise. Given the above conclusions, since the system
is in 2D, a steady state (N∗, O∗) is stable if and only if it is stable in both the O and N
directions. According to this stability analysis, the nullclines in Fig 4. lead to 3 SSS and 2
unstable steady states.
Figure 4: Nullcline stability analysis: (A) nullclines for the parameter set giving rise to 3 SSS:
m = 4, a1 = 10, b1 = 2, c1 = 7.5, k1 = 1, η1 = 0.0001, a2 = 1.8, b2 = 0.18, c2 = 2, k2 = 1, η2 =
0.0001, γ = 1, d = 20. d is chosen to reduce Nanog levels in PE (high Oct4) so they remain under
levels in ESC. The vector field is plotted using Mathematica V10.0.2.0. (B) Sign of the vector field
in the O direction in the proximity of the nullcline O˙ = 0 (C) Sign of the vector field in the N
direction in the proximity of the nullcline N˙ = 0.
3 Reprogramming Using Overexpression
In a 2006 report by Yamanaka and colleagues, a small cocktail of only 4 transcription factors
(among which were Oct4 and Sox2) was identified as the sole requirement for reprogramming
differentiated cells into stem cells [12]. In this experiment, adult fibroblast cells were induced
into pluripotent stem cells using the transcription factor cocktail. Since then, a variety [13]
of differentiated cells and experimental conditions have been used to produce iPS cells, yet
the efficiency of reprogramming, which is the number of iPS cell colonies per starting cell
number, remains around 1% or much less [14–16].
Here we use nullcline analysis to provide a possible explanation as to why current tech-
niques show this systematic failure after nearly 10 years of practice. In overexpression
experiments, transcription factors are produced in excess in a cell using viral and non-viral
vectors [45]. Specifically, the genes encoding the transcription factors are inserted into these
vectors under the control of constitutive or inducible promoters. This effectively increases
the production rate of the factors. In our model, we therefore treat this overexpression as
an additional constant term added to the production rate of the factors. This leads to the
overexpression model:
Σ′2D
dN
dt
=
a1O
2 + b1N
2 + c1O
2N2 + η1
1 +O2 +N2 +O2N2 + dO4
− k1N + u1, (15)
dO
dt
=
a2O
2 + b2N
2 + c2O
2N2 + η2
1 +O2 +N2 +O2N2
− k2O + u2. (16)
in which u1 and u2 are positive and can be effectively viewed as inputs to the system. The
nullclines change to
N∗ =
√
k2O∗ − a2O∗2 + k2O∗3 − η2 − u2(1 +O∗2)
b2 − k2O∗ + c2O∗2 − k2O∗3 + u2(1 + γO∗2) , (17)
O∗+/− =
{
1
2(dk1N∗ − du1)
[
− γk1N∗3 + (c1 + u1γ)N∗2 − k1N∗ + u1 + a1 ± Zˆ
]}1/2
, (18)
where we have defined
Zˆ :=
1
2(dk1N∗ − du1)
{[
γk1N
∗3 − (u1γ + c1)N∗2
+ k1N
∗ − a1 − u1
]2 − 4[dk1N∗ − du1] · [− u1 − η1
+ k1N
∗ − (b1 + u1)N∗2 + k1N∗3
]}1/2
. (19)
We use these nullclines to demonstrate the potential problem in seeking to force tran-
sitions from a differentiated state to the ESC state with constant inputs u1 and u2. In
Figure 5: Oct4 overexpression summary: (A) Number of SSS as a function of Oct4 overexpression
intensity, u2. (B) For u2 = 0.05, the ESC state disappears. (C) For an even higher overexpression
intensity, u2 = 0.2, the TR and ESC states disappear, leaving only the PE state. (D) For specific
values of u2 ≈ 0.005, a near intersection occurs between the nullclines in the region where the ESC
state originally was (Fig. 4A) (E) When u2 ≈ 0.005 (as in Fig. 5D) and a cell in the TR state
is pushed out of its basin of attraction due to noise, it makes a transition to the PE state. In the
interim, it spends time at the near-intersection close to the original ESC state (Fig. 4A). (F) If Oct4
overexpression is stopped suddenly due to dilution or degradation in the beginning of the interim
state in (E), the transitioning cell settles into the original ESC state, and is thus reprogrammed into
an iPS cell.
particular, we start with modeling reprogramming experiments with only the overexpres-
sion of Oct4 (employing u2 > 0, u1 = 0), which has been used to produce iPS cells on its
own from various differentiated cells [46–51]. We specifically model an experiment repro-
gramming the TR state to ESC using only Oct4, as in [51]. For the sake of completeness, we
then consider reprogramming experiments with only Nanog overexpression (u1 > 0, u2 = 0).
3.1 Oct4 Overexpression: u2 > 0, u1 = 0
3.1.1 Disappearing ESC State Compatible with Experimental Failure
Fig. 5 summarizes the shapes of the modified nullclines for different values of Oct4 overex-
pression, u2. The chart in Fig. 5A shows three regimes for the number of SSS as a function
of u2. There are 3 SSS for u2 ≈ 0 (Fig. 4), 2 SSS for intermediate values of u2 (Fig. 5B),
and 1 SSS for large values of u2 (Fig. 5C).
In Fig. 5B, a representative value of u2 from the intermediate range causes the O˙ = 0
nullcline to change shape such that the intersection located at high Nanog, intermediate
Oct4 – the region characterizing the ESC state – disappears. The TR and PE states are
still present and stable at this value of u2, so any cell starting at these states will never
reach the ESC, which no longer exists.
In Fig. 5C, an even higher representative value of u2 causes the disappearance of the
entire S-shaped region of the O˙ = 0 nullcline, which was creating the intersection corre-
sponding to the TR state. As such, the system’s only remaining SSS is located in the PE
region (high Oct4, low/intermediate Nanog), so any cell starting in TR would be repro-
grammed into the PE state, hence missing the ESC state again.
These results support the idea that current reprogramming approaches have systemat-
ically low yields because constant overexpression shifts the nullclines in a manner to make
the stable ESC state disappear, making it impossible to drive the system towards such a
state.
3.1.2 Extremely Limited Success
Nonetheless, [51] reports success – albeit at extremely low yields – in reprogramming TRs
to ESCs with only Oct4. Our model Σ′2D is able to replicate this limited success as demon-
strated in Figs. 5E and 5F, which can be explained as follows. A narrow window of values
around u2 ≈ 0.005 results in nullclines of the form seen in Fig. 5D, in which the O˙ = 0
nullcline loses the hump in its shape enough to come very close to intersecting N˙ = 0 in the
ESC region. This near intersection provides a window of opportunity for a cell to become
an ESC.
In particular, if a cell is in the TR state and u2 ≈ 0.005, some intrinsic or extrinsic
source of noise may push it out of the TR’s basin of attraction and closer to the neighboring
unstable state (Fig. 5D). If this occurs, the cell could be repelled by the unstable state, and
would ultimately transition to the PE state as shown in Fig. 5E.
However, Fig. 5E also shows that en route to becoming a PE, the cell is temporarily
captured in a region very close to the original ESC state when u2, u1 = 0 (Fig. 4). Fig.
5F shows that if u2 approached zero during this time (due to dilution of the overexpressed
Figure 6: Nanog overexpression summary: (A) Number of SSS as a function of Nanog overex-
pression intensity, u1. (B) For u1 = 0.12, the ESC state disappears. A near intersection between
the nullclines still occurs next to where the ESC state once was (Fig. 4A) (C) For an even higher
overexpression intensity, u1 = 0.2, the TR and ESC states disappear, leaving only the PE state. (D)
When u1 ≈ 0.12 (Fig. 6B) and a cell in the TR state is pushed out of its basin of attraction due to
noise, it makes a transition to the PE state. In the interim, it spends time at the near-intersection
close to the original ESC state (Fig. 4A). (E) If overexpression is stopped suddenly due to dilution
or degradation in the beginning of the interim state in (D), the transitioning cell settles into the
original ESC state, and is thus reprogrammed into an iPS cell.
Oct4), the cell settles to the original stable ESC state, and is thus reprogrammed from TR
to ESC using only Oct4 overexpression.
The fact that successful reprogramming requires a specific value of Oct4 overexpression
levels [42,43], in addition to two other events occurring in series is one explanation for why
overexpression-based reprogramming rarely succeeds in practice.
3.2 Nanog Overexpression: u1 > 0, u2 = 0
Although we found no reports attempting to reprogram differentiated cells to ESCs via only
Nanog overexpression, we perform an analysis on Nanog analogous to the one done above
for Oct4 overexpression. We show that overexpression of Nanog also leads to disappearance
of the ESC state.
3.2.1 Disappearing ESC State Compatible with Experimental Failure
Fig. 6 summarizes the nearly equivalent results for Nanog overexpression as seen in Fig.
5 with Oct4 overexpression. Except for a certain range of values (u1 ≈ 0.12), the N˙ = 0
nullcline loses the hump in its shape, causing the disappearance of ESC states (Figs. 6B,
6C).
Figure 7: Computationally generated basins of attraction for ESC, TR, and PE states are shown
with the nullclines of the system in simulation in which Nanog is overexpressed and Oct4 is downreg-
ulated. All parameters are the equivalent to those in Fig. 4, except k2 = 1.2 to model the enhanced
degradation. Furthermore, u1 = 1.
3.2.2 Extremely Rare Success
As seen in Fig. 6D, for values of u1 ≈ 0.12, a TR cell that is pushed out of it’s basin of
attraction is then repelled by the nearby unstable state, and can be pushed towards the
PE state. Fig. 6D shows that en route to the PE state, the cell is temporary captured in
a region near the original ESC state when u2, u1 = 0. If Nanog overexpression is removed
during this temporary suspension (u1 = 0), the cell settles to the stable ESC state and is
thus reprogrammed into an iPS cell (Fig. 6E).
Although many reprogramming experiments involve the use of multiple transcription
factors, the systematic failures demonstrated here with single-factor overexpression can
be seen to carry through if both Oct4 and Nanog were overexpressed at the same time
(u1 > 0, u2 > 0). In fact, in this case the nullclines would intersect for u1 = u2 = 0.2 at
points given by the intersection of O˙ = 0 in Fig. 5C and N˙ = 0 in Fig. 6C. It can be seen
that these two nullclines intersect only once, in the PE region.
Given the slim potential for reprogramming success demonstrated by our model Σ′2D in
the previous section, we can use knowledge of the basins of attraction of the states in Fig.
4 to inform more promising reprogramming approaches. One possible approach is to use a
protease on one of the transcription factors, which has the opposite effect of overexpression
and can be modeled by an increased degradation rate, ki. In Fig. 7, we simulate one such
scenario in which Nanog is overexpressed (u1 > 0) along with an increased degradation
rate for Oct4. The figure shows the monostability of the system in the desirable basin of
attraction of the ESC, which means the system will approach the pluripotent state upon
removal of this input.
4 Conclusion
In this work, we have modeled the difficulty of iPS cell reprogramming using standard tools
from dynamical systems theory. Our study was based on understanding transitions among
basins of attraction in a multi-stable system under additive positive inputs. It is very well
known that for some bistable systems such as the toggle switch [52] or its variants [53],
one can always force transitions from any initial state to any desired basin of attraction
by suitable applications of positive additive input. In contrast to this, the structure of the
network studied in this paper does not necessarily allow such forced transitions.
In future work, we will study the general principle that makes the distinction between
networks in which such transitions can be forced with positive additive inputs, and those
in which this is not possible. We will also investigate theoretical overexpression models
that use closed-loop feedback to overcome this structural problem. Other issues such as the
instability of iPS cells once reprogrammed will also be explored.
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